wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36252683-D9C32A2F-FB6B-40BD-AF69-BA8CE7499D4C
Q36252683-D9C32A2F-FB6B-40BD-AF69-BA8CE7499D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36252683-D9C32A2F-FB6B-40BD-AF69-BA8CE7499D4C
Rituximab mediates loss of CD19 on B cells in the absence of cell death.
P2860
Q36252683-D9C32A2F-FB6B-40BD-AF69-BA8CE7499D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36252683-D9C32A2F-FB6B-40BD-AF69-BA8CE7499D4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a83ceec52d52f129824a2450aa67cb5b80fb311c
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.